# SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 1757499 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/SHPH) · [JSON](https://www.pops4.com/boards/company/SHPH.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 2, latest 2026-08-28 ([filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226040622/0001493152-26-040622-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-08-17 ([filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226038790/0001493152-26-038790-index.htm))
- Item 4.01 Auditor change: 1, latest 2026-10-22 ([filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226048112/0001493152-26-048112-index.htm))
- Item 2.05 Restructuring or exit costs: 1, latest 2025-11-21 ([filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315225024618/0001493152-25-024618-index.htm))
- Item 5.02 Director or officer change: 4, latest 2026-05-07 ([filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226021767/0001493152-26-021767-index.htm))

## Recent filings

- 8-K · filed 2026-10-22 · 4.01 Changes in Registrant's Certifying Accountant; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226048112/0001493152-26-048112-index.htm)
- 10-Q · filed 2026-09-24 · [filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226044107/0001493152-26-044107-index.htm)
- 8-K · filed 2026-09-16 · 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226042791/0001493152-26-042791-index.htm)
- 8-K · filed 2026-09-11 · 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226042299/0001493152-26-042299-index.htm)
- 8-K · filed 2026-09-02 · 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226041213/0001493152-26-041213-index.htm)
- 8-K · filed 2026-09-01 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1757499/000149315226041011/0001493152-26-041011-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001757499.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1757499

## Cite

POPS4, Edgar & Edgarette: SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/SHPH. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.